Sign In
Buy INCY
$119.80
-0.800 (-0.663%)
At Close: Aug 05, 2026
Incyte Corporation (INCY) CEO Hervé Hoppenot on Q3 2020 Results - Earnings Call Transcript
02:53pm, Thursday, 05'th Nov 2020
Incyte Corporation (INCY) CEO Hervé Hoppenot on Q3 2020 Results - Earnings Call Transcript
More than 40 Abstracts from Incyte's Oncology Portfolio Accepted for Presentation at the 62nd Annual ASH Virtual Meeting
03:55pm, Wednesday, 04'th Nov 2020
WILMINGTON, Del.--(BUSINESS WIRE)---- $INCY--More than 40 Abstracts from Incyte's Oncology Portfolio Accepted for Presentation at the 62nd Annual ASH Virtual Meeting
ACR 2020: Lilly and Incyte Highlight Positive Data for Olumiant® in Rheumatoid Arthritis
02:00pm, Monday, 02'nd Nov 2020
INDIANAPOLIS, Nov. 2, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) announced today positive data for Olumiant® (baricitinib) will be presented at ACR Convergence 2
Week In Review: CStone Out-Licenses Ex-China Rights To 2 Immunotherapies In $1.3 Billion Deal
02:28pm, Sunday, 01'st Nov 2020
CStone Pharma out-licensed global rights (ex-China) for two immuno-oncology assets to US-based EQRx in a $1.3 billion agreement. CASI Pharma in-licensed China rights to a novel antibody checkpoint rec
Incyte Ranked Second Among Science Magazine's 2020 Top Biopharma Employers
09:00am, Friday, 30'th Oct 2020
WILMINGTON, Del.--(BUSINESS WIRE)---- $INCY--Incyte Ranked Second Among Science Magazine's 2020 Top Biopharma Employers
INDIANAPOLIS, Oct. 30, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) announced today new data for baricitinib (marketed as OLUMIANT®) will be presented at the annua
IBM Retirement Fund Boosts Stock Position in Incyte Co. (NASDAQ:INCY)
06:44am, Tuesday, 20'th Oct 2020
IBM Retirement Fund raised its position in shares of Incyte Co. (NASDAQ:INCY) by 39.1% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 5,918 sha
Incyte to Report Third Quarter Financial Results
12:00am, Tuesday, 20'th Oct 2020
Incyte (Nasdaq:INCY) announced today that it has scheduled its third quarter financial results conference call and webcast for 8:00 a.m. ET on Thursda
Agios: A Look At TIBSOVO In CC Patients (NASDAQ:AGIO)
02:37pm, Monday, 19'th Oct 2020
This is the second time in 6 months that we are buying AGIOS. Last time was in April when the stock traded at $30ish; it went up to $56ish.
Sanders Morris Harris LLC Makes New $487,000 Investment in Incyte Co. (NASDAQ:INCY)
07:10am, Monday, 19'th Oct 2020
Sanders Morris Harris LLC acquired a new position in shares of Incyte Co. (NASDAQ:INCY) during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exch
Assenagon Asset Management S.A. Has $798,000 Holdings in Incyte Co. (NASDAQ:INCY)
04:24am, Sunday, 18'th Oct 2020
Assenagon Asset Management S.A. lifted its holdings in shares of Incyte Co. (NASDAQ:INCY) by 69.7% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. T
2,650 Shares in Incyte Co. (NASDAQ:INCY) Purchased by Carnegie Capital Asset Management LLC
08:56am, Friday, 16'th Oct 2020
Carnegie Capital Asset Management LLC bought a new position in shares of Incyte Co. (NASDAQ:INCY) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchang
Redpoint Investment Management Pty Ltd Sells 377 Shares of Incyte Co. (NASDAQ:INCY)
08:10am, Wednesday, 14'th Oct 2020
Redpoint Investment Management Pty Ltd lessened its holdings in Incyte Co. (NASDAQ:INCY) by 9.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission
Week In Review: $1.5 Billion Total In Week's China Deals
07:32pm, Sunday, 11'th Oct 2020
10x Genomics acquired ReadCoor, a Boston developer of In Situ technologies, for $350 million. Corvus Pharma formed a China subsidiary, Angel Pharma, to develop its three clinical-stage assets and one
Bronchiolitis Obliterans Syndrome Market Clinical Analysis 2020 Incyte Corporation, Breath Therapeutics Inc., Genentech, Inc.
11:27am, Friday, 09'th Oct 2020
Oct 09, 2020 (Market Insight Reports) --
The Bronchiolitis Obliterans Syndrome Market 2020 report is a comprehensive, professional, and in-depth research of...
